FdaApplication
NDA 219843
Identifiers
- fda_app_no: NDA219843
Properties
| Property | Value |
|---|---|
| applicant_name | ROSEMONT PHARMACEUTICALS HOLDINGS INC |
| application_type | NDA |
| approval_date | 2025-07-30 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ATMEKSI | METHOCARBAMOL | 750MG/5ML | SUSPENSION;ORAL |
| ATMEKSI | METHOCARBAMOL | 750MG(5ML) | SUSPENSION;ORAL |
2 products